Further analysis demonstrated that a negative correlation between the decreased Nurr1 protein level and the elevated miRNA-132 level in PD indicated that the combination of miR-132 and the Nurr1 might be a potential biomarker for the diagnosis of PD (Yang et al., 2019). This evidence concerns the gene NR4A2 and Parkinson disease.